Opioid Adherence and Support Through Innovative Texting Strategies
RecruitingNot applicableNCT07350148
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of treatment. The main questions it aims to answer are: 1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. What impact does daily mindfulness text message quantity have on craving, pain, forgetfulness, and withdrawal symptoms? Participants will: 1. Receive daily medication reminder text messages for at least 24 weeks (i.e., 6 months) 2. Receive up to 6 mindfulness messages per day for 4 weeks (i.e., 1 month) 3. Answer daily questions twice a day during the 4 weeks of mindfulness messages 4. Answer questions about the study when enrolling, at the end of the 4 weeks of mindfulness messages, and at 4 and 16 weeks after the end of the mindfulness messages
Study details
- Official title
- Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder
- Conditions
- Opioid Use Disorder (OUD)
- Chronic Pain
- Interventions
- Behavioral: Mindfulness text messages
- Sponsor
- University of New Mexico
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Start date
- 2025-10-13
- Primary completion
- 2027-03
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18 years of age or older * Have a cellphone that can receive text messages * Have internet access to complete study surveys * Willing to comply with all study procedures and be available for the duration of the study * Within 6 months of starting or resuming to take daily methadone or buprenorphine (or suboxone/subutex) * Able to understand study requirements and provide informed consent Exclusion Criteria: * None
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07350148